[Federal Register Volume 60, Number 140 (Friday, July 21, 1995)]
[Notices]
[Pages 37644-37646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-18026]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
[CDC-567]
Cooperative Agreement with the World Health Organization (WHO)
Summary
The Centers for Disease Control and Prevention (CDC) announces the
availability of funds for fiscal year (FY) 1995 for a cooperative
agreement with the World Health Organization (WHO) for initiatives
related to emerging infectious diseases. Approximately $100,000 is
available in FY 1995 to fund this program. It is expected that the
award will begin on or about September 1, 1995, for a 12-month budget
period within a project period of up to three years. Funding estimates
may vary and are subject to change. Continuation awards within the
project period will be made on the basis of satisfactory progress and
availability of funds.
The Public Health Service (PHS) is committed to achieving the
health promotion and disease prevention objectives of ``Healthy People
2000'', a PHS-led national activity to reduce morbidity and mortality
and to improve the quality of life. This announcement focuses on the
priority area of Immunization and Infectious Diseases. (For ordering a
copy of ``Healthy People 2000'', see the section ``Where to Obtain
Additional Information.'')
[[Page 37645]]
Authority
This program is authorized under Sections 301 and 307 of the Public
Health Service Act, 42 U.S.C. 241 and 242l, as amended.
Smoke-Free Workplace
PHS strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the non-use of all tobacco products, and
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities that receive Federal funds in which education,
library, day care, health care, and early childhood development
services are provided to children.
Eligible Applicant
Assistance will be provided only to WHO for this project. No other
applications are solicited. The program announcement and application
kit have been sent to WHO.
WHO is the only international/intergovernmental agency qualified to
conduct the activities under this cooperative agreement because it has:
A. A unique position among the world's health agencies as the
technical agency for health within the United Nations.
B. Access to all national health promotion and disease prevention
programs and potential research sites through its six regional offices
located in Washington, DC; Copenhagen, Denmark; Alexandria, Egypt;
Brazzaville, Congo; Delhi, India; and Manila, Philippines.
C. In collaboration with other international organizations, WHO
works to accomplish its mission by disseminating information related to
infectious disease program needs and services, recommends and advocates
improved policies and programs, and provides consultation and guidance
at the international, national, and local level.
D. WHO offers special opportunities for furthering research
programs through the use of unusual talent resources, populations, or
environmental conditions in other countries that are not readily
available in the United States or that provide augmentation of existing
U.S. resources.
E. WHO is uniquely qualified to conduct activities that have
specific relevance to the mission and objectives of CDC and the
potential to advance knowledge that would benefit the United States.
Purpose
The purpose of this program is to assist WHO in implementing a
coordinated plan to assist national governments and regional
authorities to improve infectious disease surveillance, build public
health infrastructure, promote applied research activities, and develop
improved infectious disease prevention and control strategies. These
efforts will lead to a better understanding of baseline infectious
disease incidence and prevalence, so that ``unusual'' disease
occurrences will be more readily recognized and accurately addressed.
As infectious diseases do not respect international boundaries,
outbreaks virtually anywhere may threaten the health of the United
States, and the improved surveillance activities will offer national,
international, and global early warning of new and unusual diseases so
that effective interventions can be promptly instituted.
Program Requirements
In carrying out the activities under this program, WHO will be
responsible for the activities under A., below, and CDC will be
responsible for the activities under B., below:
A. Recipient Activities
1. Identify geographic areas, on a global basis, for implementation
and evaluation of infectious disease surveillance activities.
2. Develop and evaluate strategies to enhance national, regional,
and global infectious disease surveillance.
3. Analyze national resources devoted to infectious disease
diagnosis to identify critical shortfalls in human, technical, and
equipment resources, then develop and implement plans to resolve
recognized deficiencies.
4. Conduct a program of applied research focusing on recognition
and response to emerging infectious diseases.
5. Build international networks of collaborating laboratories for
the rapid acquisition and exchange of surveillance and monitoring
information.
6. Coordinate activities with other relevant agencies,
organizations, and individuals to facilitate development,
implementation, and evaluation of infectious disease prevention and
control programs.
7. Monitor and evaluate program performance.
B. CDC Activities
1. Collaborate in the design of research protocols.
2. Assist in the analysis and interpretation of data generated from
each project.
3. As needed, provide other programmatic consultation and guidance
in support of the program.
4. Provide continuing updates on scientific and operational
developments in emerging infectious diseases.
5. Participate in the development of plans for the sharing and
dissemination of program and research data and information.
6. Assist in defining the scope, the development, and dissemination
of plans for emerging infectious disease prevention, research, and
control.
Evaluation Criteria
The application will be reviewed and evaluated according to the
following criteria:
A. Needs Statement: The extent to which the applicant identifies
specific needs related to the purposes of the program. (20 Points)
B. Objectives: The degree to which short-term and long-term
objectives are specific, time-phased, measurable, and realistic. (20
Points)
C. Operational Plan: The adequacy of the applicant's plan to carry
out the proposed activities. (20 Points)
D. Evaluation Plan: The extent to which the evaluation plan appears
capable of monitoring progress toward meeting project objectives. (20
Points)
E. Program Management: The extent to which proposed staff are
necessary, appropriate, and qualified to perform the proposed
activities. (20 Points)
F. Budget: The extent to which the budget is reasonable and
consistent with the purpose and objectives of the program. (Not
Weighted)
Executive Order 12372 Review
This application is not subject to review under Executive Order
12372, Intergovernmental Review of Federal Programs.
Public Health System Reporting Requirements
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance Number
The Catalog of Federal Domestic Assistance Number for this program
is 93.283.
Other Requirements
Paperwork Reduction Act
Projects that involve the collection of information from 10 or more
individuals and funded by the cooperative agreement will be subject to
review by the Office of Management and Budget
[[Page 37646]]
(OMB) under the Paperwork Reduction Act.
Human Subjects
If the proposed project involves research on human subjects, the
applicant must comply with the Department of Health and Human Services
Regulations (45 CFR Part 46) regarding the protection of human
subjects. Assurance must be provided to demonstrate that the project
will be subject to initial and continuing review by an appropriate
institutional review committee. The applicant will be responsible for
providing assurance in accordance with the appropriate guidelines and
form provided in the application kit.
Application Submission and Deadline
The WHO must submit an original and two copies of the application
Form PHS-5161-1 (Revised 7/92, OMB Number 0937-0189) to Clara M.
Jenkins, Grants Management Officer, Grants Management Branch,
Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
18, Atlanta, Georgia 30305, on or before August 21, 1995.
Where To Obtain Additional Information
If you are interested in obtaining additional information on this
program, please refer to Announcement Number 567 and contact Gordon R.
Clapp, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 314, Mailstop E-
18, Atlanta, Georgia 30305, telephone (404) 842-6508.
Programmatic technical assistance may be obtained from Pat
McConnon, National Center for Infectious Diseases, Centers for Disease
Control and Prevention (CDC), Mailstop C-12, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, telephone (404) 639-2175, Email address:
[email protected].
Please refer to Announcement Number 567 when requesting information
regarding this program.
WHO may obtain a copy of Healthy People 2000 (Full Report, Stock
No. 017-001-00474-0) or Healthy People 2000 (Summary Report, Stock No.
017-001-00473-1) referenced in the Summary through the Superintendent
of Documents, Government Printing Office, Washington, DC 20402-9325,
telephone (202) 512-1800.
Dated: July 17, 1995.
Joseph R. Carter,
Acting Associate Director for Management and Operations, Centers for
Disease Control and Prevention (CDC).
[FR Doc. 95-18026 Filed 7-20-95; 8:45 am]
BILLING CODE 4163-18-P